The
iRGD peptide loaded with iron oxide nanoparticles for
tumor targeting and tissue penetration was developed for targeted
tumor therapy and ultrasensitive MR imaging. Binding of iRGD, a
tumor homing
peptide, is mediated by
integrins, which are widely expressed on the surface of cells. Several types of small molecular drugs and nanoparticles can be transfected into cells with the help of
iRGD peptide. Thus, we postulate that
SPIO nanoparticles, which have good biocompatibility, can also be transfected into cells using iRGD. Despite the many kinds of cell labeling studies that have been performed with
SPIO nanoparticles and
RGD peptide or its analogues, only a few have applied
SPIO nanoparticles with
iRGD peptide in
pancreatic cancer cells. This paper reports our preliminary findings regarding the effect of
iRGD peptide (CRGDK/RGPD/EC) combined with
SPIO on the labeling of
pancreatic cancer cells. The results suggest that
SPIO with
iRGD peptide can enhance the positive labeling rate of cells and the uptake of
SPIO. Optimal functionalization was achieved with the appropriate concentration or concentration range of
SPIO and
iRGD peptide. This study describes a simple and economical protocol to label panc-1 cells using
SPIO in combination with
iRGD peptide and may provide a useful method to improve the sensitivity of
pancreatic cancer imaging.